Coagulation Therapies
Coagulation therapies are used to treat bleeding disorders such as haemophilia and Von Willebrand disease
- Biostate®
- MonoFix® -VF
- Prothrombinex™ - HT
- KOGENATE FS (recombinant coagulation Factor VIII octacog alpha). In December 2004, CSL Bioplasma signed a five-year distribution agreement with Bayer Australia through which CSL Bioplasma acquired the exclusive rights to distribute KOGENATE FS in Australia.
Immunoglobulins
Immunoglobulins are used to modify function of the immune system
- Intragam® P
- Normal Immunoglobulin
- Rh(D) Immunoglobulin
- CMV Immunoglobulin
- Hepatitis B Immunoglobulin
- Zoster Immunoglobulin
- Tetanus Immunoglobulin
Critical Care Products
Critical care products are used for plasma volume expansion and for replacement of albumin
- Albumex®
- Thrombotrol®
Diagnostic Products
Diagnostic products are used to determine compatibility of donor-recipient blood in transfusion settings
- ABO Monoclonal Reagents
- Reagent Red Blood Cells
Our Toll Fractionation Services
CSL Bioplasma performs plasma fractionation for Australia’s National Blood Authority, a role pivotal to Australia’s policy of self-sufficiency. CSL Bioplasma is also the national fractionator for New Zealand, Hong Kong, Malaysia and Singapore.
ZLB Behring Plasma Therapeutics
CSL Bioplasma also markets ZLB Behring’s commercial products in Asia through ZLB Behring Asia.
Back | Next |
